Major Investment Projects

Operator/initiator: Kusum Uzbekistan LLC

Location: Innovative R&D pharmaceutical cluster Tashkent Pharma Park

Stage: The project is developed, contractors have not been yet determined

Dates: Execution period: 2026

Investment amount: Expected project cost: 5 million US dollars

Operator/initiator: MASMED PHARM IMPEX LLC

Location: Innovative R&D pharmaceutical cluster Tashkent Pharma Park

Stage: Requires development and approval of predesign and design documentation

Dates: Feasibility study development period: Q2 2023

Execution period: 2026

Investment amount: Expected project cost: 47 million US dollars

Operator/initiator: Haematech

Location: Innovative R&D pharmaceutical cluster Tashkent Pharma Park

Stage: Requires development and approval of predesign and design documentation

Dates: Feasibility study development period: Q2 2023

Realisation period: 2026

Investment amount: Expected project cost: 85 million US dollars

Including:
– Pharmaceutical university
– Pharmacopeia centre
– R&D centre
– Expertise centre
– BSL-3 Laboratory
– Vivarium
– Experimental production lines

Operator/initiator: Agency for the Development of the Pharmaceutical Industry of the Republic of Uzbekistan

Location: Tashkent region, Zangiatinsky district, Uzbekistan

Stage: Construction and commissioning of the administrative buildings of the Pharmaceutical Safety Centre and Development Directorate

Dates: Phase 1 is scheduled to be commissioned in November 2027

Investment amount: 130.2 million US dollars

The project is realised in order to stimulate the comprehensive development of the pharmaceutical industry in the country, including by expanding the range of pharmaceuticals produced, conducting research and development, and training personnel in the field of pharmaceuticals qualified in accordance with international educational standards. Financing of the project is provided by preferential funds of the EDCF Fund of the Eximbank of Korea, the Fund for Reconstruction and Development of the Republic of Uzbekistan, the Fund for Support and Development of the Pharmaceutical Industry and foreign direct investment. The modular structure of the cluster with a total area of 50 hectares involves the establishment of industrial, academic, research, clinical and preclinical sectors. The cluster will host production sites of leading pharmaceutical companies producing innovative medical products, medical devices and equipment, a multi-disciplinary research university and its components, research centres, a state centre of expertise of pharmaceutical products, a data centre and other necessary infrastructure.

Operator/initiator: Zuma Pharm

Location: Tashkent region, Zangiatinsky district, Uzbekistan

Stage: Phase 1 out of 4 is completed

Dates: 2028-2033

The Company is realising the project on the construction of a manufacturing facility for the production of medical preparations in the Parkent Farm FEZ. At the moment the 1st phase is completed – the production line for biological injectable medical preparations in syringes (ready to use) and lyophilic products in vials has been launched.

Subsequent phases of realisation:
• Phase 2: production of hormonal preparations in the form of pills.
• Phase 3: release of oncological preparations in the form of injections.
• Phase 4: blood factor preparations.
Realisation timeframe: 5-10 years.

Operator/initiator: Dora Line

Location: Tashkent Pharma Park

Stage: Realisation

Dates: 2026

Investment amount: 16 million US dollars

Useful project plot: 1.5 ha, 9000 m2.